The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Tumor infiltrating immune cells in gliomas and meningiomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Macrophage Polarization Comes of Age
Mantovani, Sica, & Locati, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.001 · Cited by 1,259
Macrophages in Tumor Microenvironments and the Progression of Tumors
Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/948098 · Cited by 1,003
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Pagès, F., Kirilovsky, A., Mlecnik, B., Asslaber, M., Tosolini, M., Bindea, G., Lagorce, C., Wind, P., Marliot, F., Bruneval, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6147 · Cited by 954
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Self-citationSampson, J. H., Heimberger, A. B., Archer, G. E., Aldape, K. D., Friedman, A. H., Friedman, H. S., Gilbert, M. R., Herndon, J. E., McLendon, R. E., Mitchell, D. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.6963 · Cited by 815
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 801
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Cognitive deficits in adult patients with brain tumours
Taphoorn, M. J., & Klein, M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00680-5 · Cited by 756
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Clinical use of dendritic cells for cancer therapy
Anguille, S., Smits, E. L., Lion, E., van Tendeloo, V. F., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 700
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Barros, M. H. M., Hauck, F., Dreyer, J. H., Kempkes, B., & Niedobitek, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080908 · Cited by 594
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1
Hussain, S. F., Yang, D., Suki, D., Aldape, K., Grimm, E., & Heimberger, A. B. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-008 · Cited by 592
Wainwright, D. A., Chang, A. L., Dey, M., Balyasnikova, I. V., Kim, C. K., Tobias, A., Cheng, Y., Kim, J. W., Qiao, J., Zhang, L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0514 · Cited by 576
Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T. E., Mintz, A. H., Engh, J. A., Bartlett, D. L., Brown, C. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7744 · Cited by 567
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
Guillemin, G. J., & Brew, B. J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303114 · Cited by 525
Blocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Kunwar, S., Chang, S., Westphal, M., Vogelbaum, M., Sampson, J., Barnett, G., Shaffrey, M., Ram, Z., Piepmeier, J., Prados, M., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop054 · Cited by 483
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473
Bloch, O., Crane, C. A., Kaur, R., Safaee, M., Rutkowski, M. J., & Parsa, A. T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3314 · Cited by 458
Edin, S., Wikberg, M. L., Dahlin, A. M., Rutegård, J., Öberg, Å., Oldenborg, P.-A., & Palmqvist, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047045 · Cited by 454
Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
De Matos, L. L., Trufelli, D. C., De Matos, M. G. L., & Da Silva Pinhal, M. A. (2010) · Biomarker Insights · doi:10.4137/bmi.s2185 · Cited by 437
Immune surveillance in the central nervous system
Ousman, S. S., & Kubes, P. (2012) · Nature Neuroscience · doi:10.1038/nn.3161 · Cited by 436
Schuster, J., Lai, R. K., Recht, L. D., Reardon, D. A., Paleologos, N. A., Groves, M. D., Mrugala, M. M., Jensen, R., Baehring, J. M., Sloan, A., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou348 · Cited by 422
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Nelson, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001323 · Cited by 416
The role of microglia in central nervous system immunity and glioma immunology
Yang, I., Han, S. J., Kaur, G., Crane, C., & Parsa, A. T. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.05.006 · Cited by 410
Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I. R., Wang, X., Eggen, B. J. L., Boddeke, H. W. G. M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116644 · Cited by 406
Kmiecik, J., Poli, A., Brons, N. H. C., Waha, A., Eide, G. E., Enger, P. Ø., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.013 · Cited by 389
Raychaudhuri, B., Rayman, P., Ireland, J., Ko, J., Rini, B., Borden, E. C., Garcia, J., Vogelbaum, M. A., & Finke, J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor042 · Cited by 359
Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial
Gehring, K., Sitskoorn, M. M., Gundy, C. M., Sikkes, S. A. M., Klein, M., Postma, T. J., van den Bent, M. J., Beute, G. N., Enting, R. H., Kappelle, A. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5765 · Cited by 348
Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G.-F., Okada, M., Balazs, M., Adany, R., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907611 · Cited by 346
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Castriconi, R., Daga, A., Dondero, A., Zona, G., Poliani, P. L., Melotti, A., Griffero, F., Marubbi, D., Spaziante, R., Bellora, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802845 · Cited by 337
Lohr, J., Ratliff, T., Huppertz, A., Ge, Y., Dictus, C., Ahmadi, R., Grau, S., Hiraoka, N., Eckstein, V., Ecker, R. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2557 · Cited by 337
Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
Heimberger, A. B., Abou-Ghazal, M., Reina-Ortiz, C., Yang, D. S., Sun, W., Qiao, W., Hiraoka, N., & Fuller, G. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0320 · Cited by 332
Kunwar, S., Prados, M. D., Chang, S. M., Berger, M. S., Lang, F. F., Piepmeier, J. M., Sampson, J. H., Ram, Z., Gutin, P. H., Gibbons, R. D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1117 · Cited by 325
Immune microenvironments in solid tumors: new targets for therapy
Shiao, S. L., Ganesan, A. P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 322
TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
Crane, C. A., Han, S. J., Barry, J. J., Ahn, B. J., Lanier, L. L., & Parsa, A. T. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop009 · Cited by 322
Hussain, S. F., Kong, L.-Y., Jordan, J., Conrad, C., Madden, T., Fokt, I., Priebe, W., & Heimberger, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1243 · Cited by 314
Andaloussi, A. E., & Lesniak, M. S. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-006 · Cited by 311
Muraille, E., Leo, O., & Moser, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00603 · Cited by 311
Capuron, L., Ravaud, A., & Dantzer, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2143 · Cited by 294
Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas
Badie, B., & Schartner, J. M. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00035 · Cited by 278
Lossinsky, A. S., & Shivers, R. R. (2004) · PubMed · doi:10.14670/hh-19.535 · Cited by 272
Gabrusiewicz, K., Ellert-Miklaszewska, A., Lipko, M., Sielska, M., Frankowska, M., & Kaminska, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023902 · Cited by 257
Dual Roles for Perivascular Macrophages in Immune-to-Brain Signaling
Serrats, J., Schiltz, J. C., García-Bueno, B., van Rooijen, N., Reyes, T. M., & Sawchenko, P. E. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.032 · Cited by 253
Jacobs, J. F. M., Idema, A. J., Bol, K. F., Nierkens, S., Grauer, O. M., Wesseling, P., Grotenhuis, J. A., Hoogerbrugge, P. M., de Vries, I. J. M., & Adema, G. J. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-104 · Cited by 250
Rodrigues, J. C., Gonzalez, G. C., Zhang, L., Ibrahim, G., Kelly, J. J., Gustafson, M. P., Lin, Y., Dietz, A. B., Forsyth, P. A., Yong, V. W., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop023 · Cited by 244
Scott, A. M., Lee, F.-T., Tebbutt, N., Herbertson, R., Gill, S. S., Liu, Z., Skrinos, E., Murone, C., Saunder, T. H., Chappell, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611693104 · Cited by 222
Rand, R. W., Kreitman, R. J., Patronas, N., Varricchio, F. E., Pastan, I. H., & Puri, R. K. (2000) · PubMed · Cited by 222
Systematic review of supportive care needs in patients with primary malignant brain tumors
Ford, E., Catt, S., Chalmers, A., & Fallowfield, L. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor229 · Cited by 219
Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I. H., & Puri, R. K. (1995) · PubMed · Cited by 216
Hau, P., Jachimczak, P., Schlingensiepen, R., Schulmeyer, F., Jauch, T., Steinbrecher, A., Brawanski, A., Proescholdt, M., Schlaier, J., Buchroithner, J., et al. (2007) · Oligonucleotides · doi:10.1089/oli.2006.0053 · Cited by 215
Quijano, S., López, A., Manuel Sancho, J., Panizo, C., Debén, G., Castilla, C., Antonio García-Vela, J., Salar, A., Alonso-Vence, N., González-Barca, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7089 · Cited by 215
Self-citationMyeloid‐derived suppressor cells in cancer: recent progress and prospects
Khaled, Y. S., Ammori, B. J., & Elkord, E. (2013) · Immunology & Cell Biology · doi:10.1038/icb.2013.29 · Cited by 209
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · PubMed · Cited by 192
Predina, J., Eruslanov, E., Judy, B., Kapoor, V., Cheng, G., Wang, L.-C., Sun, J., Moon, E. K., Fridlender, Z. G., Albelda, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211850110 · Cited by 188
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Sampson, J. H., Crotty, L. E., Lee, S., Archer, G. E., Ashley, D. M., Wikstrand, C. J., Hale, L. P., Small, C., Dranoff, G., Friedman, A. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130166597 · Cited by 188
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.737.3.6 · Cited by 177
Parney, I. F., Waldron, J. S., & Parsa, A. T. (2009) · Journal of Neurosurgery · doi:10.3171/2008.7.jns08475 · Cited by 173
Brain dendritic cells: biology and pathology
D’Agostino, P. M., Gottfried-Blackmore, A., Anandasabapathy, N., & Bulloch, K. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1018-0 · Cited by 173
Bethke, K., Staib, F., Distler, M., Schmitt, U., Jonuleit, H., Enk, A. H., Galle, P. R., & Heike, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6141 · Cited by 165
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Yao, S., Zhu, Y., Zhu, G., Augustine, M. M., Zheng, L., Goode, D. J., Broadwater, M., Ruff, W. E., Flies, S. J., Xu, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.014 · Cited by 165
Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
Sharda, D. R., Yu, S., Ray, M., Squadrito, M. L., Palma, M. D., Wynn, T. A., Morris, S. M., & Hankey, P. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003460 · Cited by 161
Saio (2009) · International Journal of Oncology · doi:10.3892/ijo_00000292 · Cited by 150
Sielska, M., Przanowski, P., Wylot, B., Gabrusiewicz, K. R., Maleszewska, M., Kijewska, M., Zawadzka, M., Kucharska, J., Vinnakota, K., Kettenmann, H., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4192 · Cited by 147
Yang, I., Han, S. J., Sughrue, M. E., Tihan, T., & Parsa, A. T. (2011) · Journal of neurosurgery · doi:10.3171/2011.4.jns101172 · Cited by 146
Andaloussi, A. E., & Lesniak, M. S. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9314-y · Cited by 142
Flow cytometric characterization of cerebrospinal fluid cells
de Graaf, M. T., de Jongste, A. H. C., Kraan, J., et al. (2011) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20603 · Cited by 139
Jarboe, J. S., Johnson, K. R., Choi, Y., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1493 · Cited by 139
Impaired capacity for upregulation of MHC class II in tumor‐associated microglia
Schartner, J. M., Hagar, A. R., Handel, M. M. V., Zhang, L., Nadkarni, N. V., & Badie, B. (2005) · Glia · doi:10.1002/glia.20201 · Cited by 134
Microglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126
Okano, F., Storkus, W. J., Chambers, W. H., Pollack, I. F., & Okada, H. (2002) · PubMed · Cited by 123
Wu, G. J., Yang, W., Barth, R. F., Kawabata, S., Swindall, M., Bandyopadhyaya, A. K., Tjarks, W., Khorsandi, B., Blue, T. E., Ferketich, A. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2399 · Cited by 121
Candolfi, M., Curtin, J. F., Yagiz, K., Assi, H. H., Wibowo, M., Alzadeh, G. E., Foulad, D. S., Muhammad, A. G., Salehi, S., Keech, N., et al. (2011) · Neoplasia · doi:10.1593/neo.11024 · Cited by 120
Expression of Fas ligand by microglia: possible role in glioma immune evasion
Badie, B., Schartner, J. M., Prabakaran, S., Paul, J. S., & Vorpahl, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00361-7 · Cited by 119
Increased Glioma Growth in Mice Depleted of Macrophages
Galarneau, H., de Villeneuve, J. P., Gowing, G., Julien, J., & Vallières, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0177 · Cited by 112
Innate immune functions of microglia isolated from human glioma patients
Hussain, S. F., Yang, D. S., Suki, D., Grimm, E. A., & Heimberger, A. B. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-15 · Cited by 109
Johns, T. G., Luwor, R. B., Murone, C., Walker, F., Weinstock, J., Vitali, A. A., Perera, R. M., Jungbluth, A. A., Stockert, E., Old, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036503100 · Cited by 107
Perera, R. M., Narita, Y., Furnari, F. B., Gan, H. K., Murone, C., Ahlkvist, M., Luwor, R. B., Burgess, A. W., Stockert, E., Jungbluth, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2653 · Cited by 103
Yang, W., Barth, R. F., Wu, G. J., Kawabata, S., Sferra, T. J., Bandyopadhyaya, A. K., Tjarks, W., Ferketich, A. K., Moeschberger, M. L., Binns, P. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0141 · Cited by 103
Fang, L., Lowther, D. E., Meizlish, M. L., Anderson, R. C. E., Bruce, J. N., Devine, L., Huttner, A. J., Kleinstein, S. H., Lee, J. Y., Stern, J. N. H., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not110 · Cited by 94
Audoy-Rémus, J., Richard, J.-F., Soulet, D., Zhou, H., Kubes, P., & Vallières, L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3510-08.2008 · Cited by 93
Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1α activation
Wang, X., Li, C., Chen, Y., Hao, Y., Zhou, W., Chen, C., & Yu, Z. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.055 · Cited by 88
Domingues, P. H., Teodósio, C., Ortiz, J., Sousa, P., Otero, Á., Maíllo, A., Bárcena, P., García-Macías, M. C., Lopes, M. C., Oliveira, C. R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.033 · Cited by 88
Self-citationIL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection
Xin, J., Wainwright, D. A., Mesnard, N. A., Serpe, C. J., Sanders, V. M., & Jones, K. J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.08.004 · Cited by 80
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
Alizadeh, D., Zhang, L., Brown, C. E., Farrukh, O., Jensen, M. C., & Badie, B. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3087 · Cited by 78
Kmiecik, J., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1265-5 · Cited by 76
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
Kowarik, M. C., Grummel, V., Wemlinger, S. M., Buck, D., Weber, M. S., Berthele, A., & Hemmer, B. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7145-2 · Cited by 75
Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients
Zisakis, A., Piperi, C., Themistocleous, M. S., Korkolopoulou, P. A., Boviatsis, E. I., Sakas, D. E., Patsouris, E., Lea, R. W., & Kalofoutis, A. (2007) · Cytokine · doi:10.1016/j.cyto.2007.05.012 · Cited by 73
Intratumoral T Cell Subset Ratios and Fas Ligand Expression on Brain Tumor Endothelium
Yu, J. S., Lee, P. K., Ehtesham, M., Samoto, K., Black, K. L., & Wheeler, C. J. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700020 · Cited by 73
Tumour-infiltrating T-cell subpopulations in glioblastomas
Kim, Y., Jung, T., Jung, S., Jang, W., Moon, K., Kim, I., Lee, M. C., & Lee, J. (2011) · British Journal of Neurosurgery · doi:10.3109/02688697.2011.584986 · Cited by 73
Brain Lesions Manifesting as Psychiatric Disorders:Eight Cases
Bunevičius, A., Deltuva, V. P., Deltuvienė, D., Tamašauskas, A., & Bunevičius, R. (2008) · CNS Spectrums · doi:10.1017/s1092852900014000 · Cited by 71
Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development
Kohanbash, G., & Okada, H. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.689591 · Cited by 71
Huang, Y., Hoffman, C. E., Rajappa, P., Kim, J. H., Hu, W., Huse, J. T., Tang, Z., Li, X., Weksler, B. B., Bromberg, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1072 · Cited by 69
Recent developments on immunotherapy for brain cancer
Wainwright, D. A., Nigam, P., Thaçi, B., Dey, M., & Lesniak, M. S. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.679929 · Cited by 67
Immune cell infiltration of intrinsic and metastatic intracranial tumours.
Strik, H. M., Stoll, M., & Meyermann, R. (2004) · PubMed · Cited by 62
Role of the systemic immune system in brain metastasis
Hamilton, A., & Sibson, N. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.004 · Cited by 56
Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas
Mineo, J. ‐., Bordron, A., Quintin‐Roué, I., Loisel, S., Ster, K. L., Buhé, V., Lagarde, N., & Berthou, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602089 · Cited by 55
Neurobehavioural changes in patients following brain tumour: patients and relatives perspective
Gregg, N., Arber, A., Ashkan, K., Brazil, L., Bhangoo, R. S., Beaney, R. P., GULLAN, R. W., Hurwitz, V., Costello, A. D. L., & Yágüez, L. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2291-3 · Cited by 43
Immunohistochemical characterization of brain-invasive meningiomas.
Backer‐Grøndahl, T., Moen, B. H., Arnli, M., Torseth, K., & TORP, S. H. (2014) · PubMed Central · Cited by 43
Biollaz, G., Bernasconi, L., Cretton, C., Püntener, U., Frei, K., Fontana, A., & Suter, T. B. (2009) · European Journal of Immunology · doi:10.1002/eji.200838921 · Cited by 41
Beyond laser microdissection technology: follow the yellow brick road for cancer research.
Legrès, L., Janin, A., Masselon, C., & Bertheau, P. (2014) · Europe PMC (PubMed Central) · Cited by 40
The microglial/macrophagic response at the tumour–brain border of invasive meningiomas
Grund, S., Schittenhelm, J., Röser, F., et al. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00960.x · Cited by 40
Hoepner, S., Loh, J. M. S., Riccadonna, C., Derouazi, M., Maroun, C. Y., Dietrich, P., & Walker, P. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063933 · Cited by 40
Maes, W., Verschuere, T., Hoylandt, A. V., Boon, L., & Gool, S. V. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/952469 · Cited by 40
Sun, W., Depping, R., & JELKMANN, W. E. B. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.562 · Cited by 38
Profound tumor-specific Th2 bias in patients with malignant glioma
Shimato, S., Maier, L. M., Maier, R., Bruce, J. N., Anderson, R. C. E., & Anderson, D. E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-561 · Cited by 35
Central nervous system: A modified immune surveillance circuit?
Romo‐González, T., Chavarría, A., & Pérez-H, J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.01.016 · Cited by 34
Emerging applications of flow cytometry in solid tumor biology
Chang, Q., & Hedley, D. W. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.027 · Cited by 33
Jun-ichirou, A. S. A. I., Suzuki, R., Fujimoto, T., Suzuki, T., Nakagawa, N., Nagashima, G., Takayasu, M. I. Y. O., Hokaku, H., & Takei, A. (1999) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(99)00052-9 · Cited by 32
Gousias, K., von Ruecker, A., Voulgari, P. V., & Simon, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.001 · Cited by 27
Domingues, P. H., Teodósio, C., Otero, Á., Sousa, P., Gonçalves, J. M., Librero, A. B. N., Lopes, M. C., Oliveira, C. R., Órfão, A., & Tabernero, M. D. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12127 · Cited by 17
Self-citationModulation of Tumor Tolerance in Primary Central Nervous System Malignancies
Johnson, T. S., Munn, D. H., & Maria, B. L. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/937253 · Cited by 15
Legrès, L., Janin, A., Masselon, C., & Bertheau, P. (2014) · Cited by 2
Cited by
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11719-3 · Cited by 300
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
D’Alessio, A., Proietti, G., Sica, G., & Scicchitano, B. M. (2019) · Cancers · doi:10.3390/cancers11040469 · Cited by 275
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Metadata
- Authors
- Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruiz, L., Sousa, P., Ciudad, J., Gonçalves, J. M., Lopes, M. C., Orfao, A., & Tabernero, M. D.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2016-03
- Volume
- 53
- Pages
- 1-15
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W1861274688
- Cited by
- 302
- References
- 129
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.